1. Home
  2. PMCB vs AUUD Comparison

PMCB vs AUUD Comparison

Compare PMCB & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.34

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$0.98

Market Cap

5.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
AUUD
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.8M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
PMCB
AUUD
Price
$0.34
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.1K
★ 923.6K
Earning Date
09-14-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.82
52 Week High
$1.51
$38.64

Technical Indicators

Market Signals
Indicator
PMCB
AUUD
Relative Strength Index (RSI) 33.27 42.52
Support Level $0.33 $0.90
Resistance Level $0.85 $1.45
Average True Range (ATR) 0.03 0.10
MACD -0.00 -0.02
Stochastic Oscillator 8.64 10.43

Price Performance

Historical Comparison
PMCB
AUUD

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

Share on Social Networks: